Your browser doesn't support javascript.
loading
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial.
Hagel, Christian; Sloman, Veronika; Mynarek, Martin; Petrasch, Katharina; Obrecht, Denise; Kühl, Joachim; Deinlein, Frank; Schmid, Renate; von Bueren, André O; Friedrich, Carsten; Juhnke, B Ole; Gerber, Nicolas U; Kwiecien, Robert; Girschick, Hermann; Höller, Alexandra; Zapf, Antonia; von Hoff, Katja; Rutkowski, Stefan.
Afiliação
  • Hagel C; Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany. Electronic address: hagel@uke.de.
  • Sloman V; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Petrasch K; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Obrecht D; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Kühl J; Department of Pediatric Hematology and Oncology, University Children's Hospital Wuerzburg, Germany.
  • Deinlein F; Department of Pediatric Hematology and Oncology, University Children's Hospital Wuerzburg, Germany.
  • Schmid R; Department of Pediatric Hematology and Oncology, University Children's Hospital Wuerzburg, Germany.
  • von Bueren AO; Department of Pediatrics, Obstetrics and Gynecology, Division of Pediatric Hematology and Oncology, University Hospital of Geneva, Geneva, Switzerland.
  • Friedrich C; Department of General Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Klinikum Oldenburg AöR, Oldenburg, Germany.
  • Juhnke BO; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Gerber NU; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Kwiecien R; Institut für Biometrie und Klinische Forschung, Universitätsklinikum Münster, Münster, Germany.
  • Girschick H; Kinder- und Jugendmedizin, Vivantes-Klinikum, Berlin Friedrichshain, Berlin, Germany.
  • Höller A; Institute of Medical Biometry and Epidemiology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Zapf A; Institute of Medical Biometry and Epidemiology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • von Hoff K; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany; Department of Pediatric Oncology/Hematology, Charité-University Medicine Berlin, Germany.
  • Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Eur J Cancer ; 164: 30-38, 2022 03.
Article em En | MEDLINE | ID: mdl-35151105
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article